JMI LABS IS NOW PART OF LEARN MORE

Multicenter Studies to Establish Tigecycline Disk Diffusion Susceptibility Breakpoints when Testing Acinetobacter spp

Multicenter Studies to Establish Tigecycline Disk Diffusion Susceptibility Breakpoints when Testing Acinetobacter spp, Lead author: Jones RN, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida

Assessment of Colistin and Polymyxin B Antimicrobial Susceptibility Testing Methods Against Non-Fermentative Gram-Negative Bacilli (NFGNB)

Assessment of Colistin and Polymyxin B Antimicrobial Susceptibility Testing Methods Against Non-Fermentative Gram-Negative Bacilli (NFGNB), Lead author: Sader HS, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida

Disk Diffusion Susceptibility Testing of Campylobacter spp.: Use in Detection of Resistance to Macrolides and Fluoroquinolones

Disk Diffusion Susceptibility Testing of Campylobacter spp.: Use in Detection of Resistance to Macrolides and Fluoroquinolones, Lead author: Fritsche TR, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida

Antimicrobial Activity of Daptomycin Tested Against Gram-Positive Strains Collected from European Medical Centres in 2005: Results of the Daptomycin Surveillance Programme

Antimicrobial Activity of Daptomycin Tested Against Gram-Positive Strains Collected from European Medical Centres in 2005: Results of the Daptomycin Surveillance Programme, Lead author: Streit J, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Antimicrobial Activity of Cefepime Tested Against Ceftazidime-Resistant Gram-Negative Clinical Strains from North American Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 1998-2004

Antimicrobial Activity of Cefepime Tested Against Ceftazidime-Resistant Gram-Negative Clinical Strains from North American Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 1998-2004, Lead author: Sader HS, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Frequency of Occurrence and Antimicrobial Susceptibility of Bacterial Isolates Causing Bloodstream Infections in European Medical Centers: Report from 9 years of the SENTRY Antimicrobial Surveillance Program in Europe (1997-2005)

Frequency of Occurrence and Antimicrobial Susceptibility of Bacterial Isolates Causing Bloodstream Infections in European Medical Centers: Report from 9 years of the SENTRY Antimicrobial Surveillance Program in Europe (1997-2005), Lead author: Sader HS, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Antimicrobial Potency and Spectrum of Activity for Meropenem: Report from the USA MYSTIC Programme (2005)

Antimicrobial Potency and Spectrum of Activity for Meropenem: Report from the USA MYSTIC Programme (2005), Lead author: Rhomberg PR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

In Vitro Efficacy of Tigecycline Tested Against Community-Associated Methicillin-Resistant S. aureus (CA-MRSA) Including Analyses of 72 Co-Resistance Patterns

In Vitro Efficacy of Tigecycline Tested Against Community-Associated Methicillin-Resistant S. aureus (CA-MRSA) Including Analyses of 72 Co-Resistance Patterns, Lead author: Jones RN, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

In Vitro Activity of Tigecycline Tested Against an International Collection of Minocycline-Resistant Bacterial Pathogens (2000-2004)

In Vitro Activity of Tigecycline Tested Against an International Collection of Minocycline-Resistant Bacterial Pathogens (2000-2004), Lead author: Fritsche TR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Antimicrobial Activity of Tigecycline, a Glycylcycline, Tested Against Carbapenemase-Producing Enterobactereaceae

Antimicrobial Activity of Tigecycline, a Glycylcycline, Tested Against Carbapenemase-Producing Enterobactereaceae, Lead author: Sader HS, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Activity of Tigecycline Tested Against an International Collection (2000-2004) of AmpC-Producing Enterobacteriaceae

Activity of Tigecycline Tested Against an International Collection (2000-2004) of AmpC-Producing Enterobacteriaceae, Lead author: Fritsche TR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Five Year Evaluation of Clonal Dissemination and Expansion of VIM-1 Producing Enterobacteriaceae in Greece: A Report from the SENTRY Antimicrobial Surveillance Program (2001-2005)

Five Year Evaluation of Clonal Dissemination and Expansion of VIM-1 Producing Enterobacteriaceae in Greece: A Report from the SENTRY Antimicrobial Surveillance Program (2001-2005), Lead author: Sader HS, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

VIM-1 producing Enterobacter cloacae strains from Madrid, Spain: Report from the SENTRY Antimicrobial Surveillance Program 2005

VIM-1 producing Enterobacter cloacae strains from Madrid, Spain: Report from the SENTRY Antimicrobial Surveillance Program 2005, Lead author: Deshpande LM, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Comparison of Dalbavancin MIC Values Tested Against Gram-Positive Organisms Using Etest (AB BIODISK) and Reference Dilution Methods

Comparison of Dalbavancin MIC Values Tested Against Gram-Positive Organisms Using Etest (AB BIODISK) and Reference Dilution Methods, Lead author: Jones RN, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Re-evaluation of the Role of Broad-Spectrum Cephalosporins against Staphylococci Applying Contemporary In Vitro Results and Pharmacokinetic-Pharmacodynamic (PK-PD) Principals

Re-evaluation of the Role of Broad-Spectrum Cephalosporins against Staphylococci Applying Contemporary In Vitro Results and Pharmacokinetic-Pharmacodynamic (PK-PD) Principals, Lead author: Sader HS, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Potency of Garenoxacin Tested Against an International Collection of Staphylococcus aureus Isolates, Including Oxacillin- and Ciprofloxacin-Resistant Subsets (2004-2005)

Potency of Garenoxacin Tested Against an International Collection of Staphylococcus aureus Isolates, Including Oxacillin- and Ciprofloxacin-Resistant Subsets (2004-2005), Lead author: Fritsche TR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Garenoxacin Activity Tested Against S. pneumoniae, H. influenzae and M. catarrhalis with Elevated or Resistant Fluoroquinolone MIC Values

Garenoxacin Activity Tested Against S. pneumoniae, H. influenzae and M. catarrhalis with Elevated or Resistant Fluoroquinolone MIC Values, Lead author: Jones RN, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Evaluation of Garenoxacin (GRN) Activity Tested Against All Patterns of Multi-Resistant (MDR) S. pneumoniae: Multi-Center Studies of Nearly 15,000 Isolates

Evaluation of Garenoxacin (GRN) Activity Tested Against All Patterns of Multi-Resistant (MDR) S. pneumoniae: Multi-Center Studies of Nearly 15,000 Isolates, Lead author: Jones RN, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Garenoxacin Activity and Potency against S. pneumoniae and H. influenzae Respiratory Tract Isolates (2004-2005): Report from a Worldwide Surveillance Network

Garenoxacin Activity and Potency against S. pneumoniae and H. influenzae Respiratory Tract Isolates (2004-2005): Report from a Worldwide Surveillance Network, Lead author: Jones RN, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

In Vitro Activity of Garenoxacin Tested Against Ciprofloxacin-Susceptible and -Resistant Enterobacteriaceae and Acinetobacter spp. Strains Collected Worldwide by the SENTRY Antimicrobial Surveillance Program (2004-2005)

In Vitro Activity of Garenoxacin Tested Against Ciprofloxacin-Susceptible and -Resistant Enterobacteriaceae and Acinetobacter spp. Strains Collected Worldwide by the SENTRY Antimicrobial Surveillance Program (2004-2005), Lead author: Sader HS, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Contemporary Prevalence of BRO β-Lactamases in M. catarrhalis: Report from the SENTRY Antimicrobial Surveillance Program (USA; 1997-2004)

Contemporary Prevalence of BRO β-Lactamases in M. catarrhalis: Report from the SENTRY Antimicrobial Surveillance Program (USA; 1997-2004), Lead author: Deshpande LM, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Doripenem (DOR) European Surveillance: Antimicrobial Activity Against 6,480 Contemporary Pathogens (2004)

Doripenem (DOR) European Surveillance: Antimicrobial Activity Against 6,480 Contemporary Pathogens (2004), Lead author: Fritsche TR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Analysis of Skin and Soft Tissue Infections in European Medical Centers: Report from the SENTRY Antimicrobial Surveillance Program (1998-2005).

Analysis of Skin and Soft Tissue Infections in European Medical Centers: Report from the SENTRY Antimicrobial Surveillance Program (1998-2005)., Lead author: Moet G, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Changing Patterns of Antimicrobial Resistances Among Bacterial Isolates Recovered from European Patients Hospitalized with Pneumonia: Report from the SENTRY Antimicrobial Surveillance Programme (1998-2004)

Changing Patterns of Antimicrobial Resistances Among Bacterial Isolates Recovered from European Patients Hospitalized with Pneumonia: Report from the SENTRY Antimicrobial Surveillance Programme (1998-2004), Lead author: Fritsche TR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Cefepime Tested Alone and in Combination with Clavulanic Acid, Gentamicin, and Tobramycin Against Clinical Isolates of Methicillin-Resistant Staphylococcus aureus

Cefepime Tested Alone and in Combination with Clavulanic Acid, Gentamicin, and Tobramycin Against Clinical Isolates of Methicillin-Resistant Staphylococcus aureus, Lead author: Rybak M, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Metallo-Beta-Lactamase Gene blaSPM-1: Evaluation of its vicinities in unrelated P. aeruginosa strains isolated from distinct Brazilian Hospitals

Metallo-Beta-Lactamase Gene blaSPM-1: Evaluation of its vicinities in unrelated P. aeruginosa strains isolated from distinct Brazilian Hospitals, Lead author: Castanheira M, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Discrepancy in the metallo-beta-lactamase phenotypic tests results associated with diversity in the promoter region of class 1 integrons

Discrepancy in the metallo-beta-lactamase phenotypic tests results associated with diversity in the promoter region of class 1 integrons, Lead author: Castanheira M, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Survey of bloodstream infection isolates: SENTRY Antimicrobial Surveillance Program in Buenos Aires, Argentina (1997-2002).

Survey of bloodstream infection isolates: SENTRY Antimicrobial Surveillance Program in Buenos Aires, Argentina (1997-2002). by Vargas LJ, Casellas JM, Gales A, Tome A, Sader HS, Lanza A, Jones RN and Smayevsky J published in Rev. Panam. Infectol. 2006; 8 (3): 11-17

Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates.

Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates. by Jevitt LA, Thorne GM, Traczewski MM, Jones RN, McGowan JE, Tenovera FC and Brown SD published in J. Clin. Microbiol. 2006; 44 (9): 3098-3104

Contemporary prevalence of BRO β-lactamases in Moraxella catarrhalis: Report from the SENTRY Antimicrobial Surveillance Program (North America, 1997 to 2004).

Contemporary prevalence of BRO β-lactamases in Moraxella catarrhalis: Report from the SENTRY Antimicrobial Surveillance Program (North America, 1997 to 2004). by Deshpande LM, Sader HS, Fritsche TR, and RN Jones published in J. Clin. Microbiol. 2006; 44 (10): 3775-3777

Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients.

Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients. by Freitas MCS, Pacheco-Silva A, Barbosa D, Silbert S, Sader HS, Sesso R and Camargo LFA published in BMC Inf. Dis. 2006; 6: 133

Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy.

Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy. by Mariani PG, Sader HS and Jones RN published in J. Antimicrob. Chemother. 2006; 58 (2): 481-483

Emergence of multidrug-resistant Streptococcus pneumoniae: Report from the SENTRY Antimicrobial Surveillance Program (1999-2003).

Emergence of multidrug-resistant Streptococcus pneumoniae: Report from the SENTRY Antimicrobial Surveillance Program (1999-2003). by Johnson DM, Stilwell MG, Fritsche TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 56 (1): 69-74

Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patients: Report from the Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance Program (North America).

Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patients: Report from the Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance Program (North America). by Kirby JT, Fritsche TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 56 (1): 75-82

Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).

Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA). by Rhomberg PR, Fritsche TR, Sader HS and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 56 (1): 57-62

Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant Gram-positive cocci.

Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant Gram-positive cocci. by Jones RN, Fritsche TR, Sader HS and Ross JE published in Antimicrob. Agents. Chemother. 2006; 50 (7): 2583-2586

Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.

Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. by Sader HS, Fritsche TR and Jones RN published in Antimicrob. Agents Chemother. 2006; 50 (7): 2330-2336

Evaluation of dalbavancin in combination with nine antimicrobial agents to detect enhanced or antagonistic interactions.

Evaluation of dalbavancin in combination with nine antimicrobial agents to detect enhanced or antagonistic interactions. by Johnson DM, Fritsche TR, Sader HS and Jones RN published in Int. J. Antimicrob. Agents 2006; 27 (6): 557-560

Antimicrobial susceptibility of Gram-positive bacteria isolated from European Medical Centres: Results of the Daptomycin Surveillance Programme (2002-2004).

Antimicrobial susceptibility of Gram-positive bacteria isolated from European Medical Centres: Results of the Daptomycin Surveillance Programme (2002-2004). by Sader HS, Streit JM, Fritsche TR and Jones RN published in Clin. Microbiol. Infect. 2006; 12 (9): 844-852

Dissemination of IMP-1 metallo-β-lactamase-producing Acinetobacter species in a Brazilian teaching hospital.

Dissemination of IMP-1 metallo-β-lactamase-producing Acinetobacter species in a Brazilian teaching hospital. by Tognim MCB, Gales AC, Penteago A, Silbert S and Sader HS published in Infect. Control Hosp. Epidemiol. 2006; 27 (7): 742-747

Delayed resistance selection for doripenem when passaging Pseudomonas aeruginosa with doripenem plus an aminoglycoside.

Delayed resistance selection for doripenem when passaging Pseudomonas aeruginosa with doripenem plus an aminoglycoside. by Huynh HK, Biedenbach DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 55 (3): 241-243

Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: Are we evaluating the orally administered cephalosporins correctly?

Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: Are we evaluating the orally administered cephalosporins correctly? by Jones RN and Sader HS published in Diagn. Microbiol. Infect. Dis. 2006; 55 (4): 351-356

Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.

Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis. by Gales AC, Sader HS, Andrade SS, Lutz L, Machado A and Barth AL published in Int. J. Antimicrob. Agents 2006; 27 (4): 300-302

Clonal occurrences of multidrug-resistant Gram-negative bacilli: Report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004).

Clonal occurrences of multidrug-resistant Gram-negative bacilli: Report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004). by Rhomberg PR, Fritsche TR, Sader HS, Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 54 (4): 249-257

International surveillance of Candida spp. and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2003).

International surveillance of Candida spp. and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2003). by Messer SA, Jones RN and Fritsche TR published in J. Clin. Microbiol. 2006; 44 (5): 1782-1787

Susceptibility to amoxycillin-clavulanate among clinical isolates of Escherichia coli resistant to cefoxitin.

Susceptibility to amoxycillin-clavulanate among clinical isolates of Escherichia coli resistant to cefoxitin. by Fernandez-Cuenca F, Martinez-Martinez L, Amblar G, Biedenbach DJ, Jones RN and Pascual A published in Clin. Microbiol. Infect. 2006; 12 (2): 197-198

Global assessment of the antimicrobial activity of polymyxin B against 54,731 clinical isolates of Gram-negative bacilli: Report from the SENTRY Antimicrobial Surveillance Programme (2001-2004).

Global assessment of the antimicrobial activity of polymyxin B against 54,731 clinical isolates of Gram-negative bacilli: Report from the SENTRY Antimicrobial Surveillance Programme (2001-2004). by Gales AC, Jones RN and Sader HS published in Clin. Microbiol. Infect. 2006; 12 (4): 315-321

Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum β-lactam agents.

Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum β-lactam agents. by Sader HS, Fritsche TR and Jones RN published in J. Clin. Microbiol. 2006; 44 (3): 1101-1104

Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: Report from the SENTRY Antimicrobial Surveillance Program.

Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: Report from the SENTRY Antimicrobial Surveillance Program. by Bhavnani SM, Ambrose PG, Craig WA, Dudley MN and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 54 (3): 231-236

Emergence and epidemiology for fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: Report from the SENTRY Antimicrobial Surveillance Program (2001-2004).

Emergence and epidemiology for fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: Report from the SENTRY Antimicrobial Surveillance Program (2001-2004). by Deshpande LM, Sader HS, Debbia E, Nicoletti G, Fadda G and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 53 (3): 157-164